Asset Details
MbrlCatalogueTitleDetail
Do you wish to reserve the book?
Challenges and unmet needs in basal insulin therapy: lessons from the Asian experience
by
Chan, Wing Bun
, Chen, Jung Fu
, Bajpai, Shailendra
, Isip-Tan, Iris Thiele
, Mabunay, Maria Aileen
, Vu, Thi Thanh Huyen
, Mudjanarko, Sony Wibisono
, Goh, Su-Yen
, Bunnag, Pongamorn
in
Clinical medicine
/ Developing countries
/ Diabetes
/ Diabetes Mellitus
/ Dosage and administration
/ Endocrinology
/ Glucose
/ Glucose monitoring
/ Hospitals
/ Hypoglycemia
/ Insulin
/ insulin degludec
/ insulin detemir
/ insulin glargine
/ insulin titration
/ Internal medicine
/ LDCs
/ Long-acting Insulin
/ Medicine
/ Metabolism
/ patient education
/ Patients
/ Review
/ Rural areas
/ Trends
2017
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Challenges and unmet needs in basal insulin therapy: lessons from the Asian experience
by
Chan, Wing Bun
, Chen, Jung Fu
, Bajpai, Shailendra
, Isip-Tan, Iris Thiele
, Mabunay, Maria Aileen
, Vu, Thi Thanh Huyen
, Mudjanarko, Sony Wibisono
, Goh, Su-Yen
, Bunnag, Pongamorn
in
Clinical medicine
/ Developing countries
/ Diabetes
/ Diabetes Mellitus
/ Dosage and administration
/ Endocrinology
/ Glucose
/ Glucose monitoring
/ Hospitals
/ Hypoglycemia
/ Insulin
/ insulin degludec
/ insulin detemir
/ insulin glargine
/ insulin titration
/ Internal medicine
/ LDCs
/ Long-acting Insulin
/ Medicine
/ Metabolism
/ patient education
/ Patients
/ Review
/ Rural areas
/ Trends
2017
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
Challenges and unmet needs in basal insulin therapy: lessons from the Asian experience
by
Chan, Wing Bun
, Chen, Jung Fu
, Bajpai, Shailendra
, Isip-Tan, Iris Thiele
, Mabunay, Maria Aileen
, Vu, Thi Thanh Huyen
, Mudjanarko, Sony Wibisono
, Goh, Su-Yen
, Bunnag, Pongamorn
in
Clinical medicine
/ Developing countries
/ Diabetes
/ Diabetes Mellitus
/ Dosage and administration
/ Endocrinology
/ Glucose
/ Glucose monitoring
/ Hospitals
/ Hypoglycemia
/ Insulin
/ insulin degludec
/ insulin detemir
/ insulin glargine
/ insulin titration
/ Internal medicine
/ LDCs
/ Long-acting Insulin
/ Medicine
/ Metabolism
/ patient education
/ Patients
/ Review
/ Rural areas
/ Trends
2017
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Challenges and unmet needs in basal insulin therapy: lessons from the Asian experience
Journal Article
Challenges and unmet needs in basal insulin therapy: lessons from the Asian experience
2017
Request Book From Autostore
and Choose the Collection Method
Overview
Basal insulin therapy can improve glycemic control in people with type 2 diabetes. However, timely initiation, optimal titration, and proper adherence to prescribed basal insulin regimens are necessary to achieve optimal glycemic control. Even so, glycemic control may remain suboptimal in a significant proportion of patients. Unique circumstances in Asia (eg, limited resources, management of diabetes primarily in nonspecialist settings, and patient populations that are predominantly less educated) coupled with the limitations of current basal insulin options (eg, risk of hypoglycemia and dosing time inflexibility) amplify the challenge of optimal basal insulin therapy in Asia. Significant progress has been made with long-acting insulin analogs (insulin glargine 100 units/mL and insulin detemir), which provide longer coverage and less risk of hypoglycemia over intermediate-acting insulin (Neutral Protamine Hagedorn insulin). Furthermore, recent clinical evidence suggests that newer long-acting insulin analogs, new insulin glargine 300 units/mL and insulin degludec, may address some of the unmet needs of current basal insulin options in terms of risk of hypoglycemia and dosing time inflexibility. Nevertheless, more can be done to overcome barriers to basal insulin therapy in Asia, through educating both patients and physicians, developing better patient support models, and improving accessibility to long-acting insulin analogs. In this study, we highlight the unique challenges associated with basal insulin therapy in Asia and, where possible, propose strategies to address the unmet needs by drawing on clinical experiences and perspectives in Asia.
This website uses cookies to ensure you get the best experience on our website.